Comprehensive molecular characterization of gastric adenocarcinoma - Wikidata - awgldk - TriplyDB

Comprehensive molecular characterization of gastric adenocarcinoma

Comprehensive molecular characterization of gastric adenocarcinoma

http://www.wikidata.org/entity/Q28244985

about

Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma Gastric biomarkers: a global review Current and emerging therapies in unresectable and recurrent gastric cancer Emerging molecular classifications and therapeutic implications for gastric cancer Recent updates of precision therapy for gastric cancer: Towards optimal tailored management Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat Cancer Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways Paradoxical role of SOX2 in gastric cancer Epstein-Barr Virus and Gastric Cancer Risk: A Meta-analysis With Meta-regression of Case-control Studies Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response Genomic alterations and molecular subtypes of gastric cancers in Asians Molecular alterations in gastric cancer with special reference to the early-onset subtype Advanced gastric cancer: Current treatment landscape and future perspectives Novel targets in the treatment of advanced gastric cancer: a perspective review Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis Morphological and Cellular Features of Innate Immune Reaction in Helicobacter pylori Gastritis: A Brief Review Emerging role of Hippo pathway in gastric and other gastrointestinal cancers Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer Changing strategies for target therapy in gastric cancer Personalized medicine in gastric cancer: Where are we and where are we going?The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers MEK and PI3K inhibition in solid tumors: rationale and evidence to date Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis Clinical significance of MET in gastric cancer Gastric cancer: The times they are a-changin'The mutational landscape of hepatocellular carcinoma Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma Second-line treatment of metastatic gastric cancer: Current options and future directions Towards curative therapy in gastric cancer: Faraway, so close!MEF2 transcription factors: developmental regulators and emerging cancer genes Comparative Transcriptomes and EVO-DEVO Studies Depending on Next Generation Sequencing State of the art management of metastatic gastroesophageal cancer Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives Companion diagnostics for the targeted therapy of gastric cancer HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations Neoadjuvant therapy for gastric cancer: current evidence and future directions Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?

P2860

Q26741242-7588529F-5D3E-42EC-9963-51DE98E34CD7 Q26741318-6CA4B7C4-DFA9-472E-BA98-135B456AC859 Q26741530-6C1E5013-DEC9-4DD6-B001-6856F7A498D5 Q26741859-4191E428-D414-4E08-9912-89D68621BFC0 Q26745453-25A797CF-0744-4EF3-814E-0B34186045A6 Q26745525-309D0F4E-2A37-4E7D-9851-F21B52DA9137 Q26746246-3BD4D359-AD46-4EE8-8812-7EE368D319E1 Q26747651-40825765-96FA-4EF3-9311-C9055B3E0EB5 Q26748123-C8E392DD-F925-4A0E-BB10-9EE265048FE9 Q26749130-EE3F6EE8-E133-4A26-AE14-ACC00A8C499F Q26750911-E8BDF35C-B81F-43DF-BECA-7EBA14139276 Q26751029-21D73903-EBE6-433B-AE9D-5698FF827EDD Q26751062-F70EBCE1-0EC8-4545-B18F-52BA2716B5C2 Q26764919-B93201A7-3AAA-4BC6-B1B1-A2F760AEE603 Q26764934-CEC39D01-4E5E-44D8-A7CC-F7EE313F1ACB Q26765208-B7F2064B-6A3F-4BE5-A23E-AE371537E19A Q26765643-86855B16-AF9E-42F2-9897-28303E97E9F9 Q26771157-E4389F27-F3C7-4CB4-9AC9-AAA1CAFABB92 Q26774473-7D227385-FD3B-4BCF-B398-B3A1070F1DAC Q26774509-5364B2C5-6DF7-43A7-930F-CD3C9B5F4DCE Q26774513-A7C4A2A2-4DA6-4C5D-AE2F-22B0F8C1A23C Q26774521-8883046C-FF87-410E-B93B-1368D0384F6E Q26775454-D6D79E41-F84D-405A-B3E3-163E8920C0B9 Q26775573-1DF1E9AC-F5C0-45FA-B7C8-11695D439509 Q26775839-C51BBB57-19CD-4F25-9845-07657EF8C3AF Q26776190-DE78E0F9-FD0C-44B8-9758-D28F2F0B7B60 Q26776195-449AE31D-673D-4B29-8763-AEFD0B06BCD8 Q26777478-3471FF7D-4507-48C9-B54E-A4567E66F1E2 Q26777690-6D78DB91-5D2B-4587-A5E8-0831CD067B2C Q26778027-6C3ECB65-5BEB-417C-8620-4A6F32C2AC54 Q26778029-DFC0C5C9-0C31-4B99-8277-6C831C9717E2 Q26778515-4B63627B-307E-455A-AA67-D75CDAD52565 Q26778783-AC5F2B2B-6B9E-424B-A9A6-3C7C6F962A35 Q26779217-5825178A-E902-4221-8C31-EC36AE640563 Q26779725-184A6A1F-A1F9-4653-8D7E-5FCAD9CE5F74 Q26780298-84E6CE95-7C77-4861-AAF1-5D7EBA70B32C Q26780318-E27A1B29-EEE6-4C58-807D-9FD43A656AB2 Q26781038-D28CEEFE-5153-40E4-909F-7F89D1576307 Q26781043-0EC427CA-22E1-4A54-9E36-7914A6797A07 Q26781271-AB181065-2BA8-4A2D-9B00-885445E322C6

P2860

Comprehensive molecular characterization of gastric adenocarcinoma

http://www.wikidata.org/entity/Q28244985

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Comprehensive molecular characterization of gastric adenocarcinoma

@ast

Comprehensive molecular characterization of gastric adenocarcinoma

@en

Comprehensive molecular characterization of gastric adenocarcinoma

@nl

type

label

Comprehensive molecular characterization of gastric adenocarcinoma

@ast

Comprehensive molecular characterization of gastric adenocarcinoma

@en

Comprehensive molecular characterization of gastric adenocarcinoma

@nl

prefLabel

Comprehensive molecular characterization of gastric adenocarcinoma

@ast

Comprehensive molecular characterization of gastric adenocarcinoma

@en

Comprehensive molecular characterization of gastric adenocarcinoma

@nl

P1433

Q28244985-84A483D8-5FD1-43E7-B878-1C3F7E8A153A

P1476

Q28244985-3BB3EE50-DD18-4074-84C4-30529F904289

P2860

Q28244985-00FB7FC2-BBEE-4C35-A68C-E8FFEF8FB3A6

Q28244985-07FDBFF2-7561-4D8F-9874-F0F766BD59DA

Q28244985-0CCD75B0-F00F-47B0-8739-76A0EB0102FD

Q28244985-0CFCC296-315C-4509-9E98-75DDE537EBA3

Q28244985-1E2CBEBF-639A-42E4-8BCE-0F1B9CC19E95

Q28244985-274A4D2F-3FEA-4311-9046-9CF88EC05A99

Q28244985-2F9D904F-2F44-4237-94B4-5E0B399D23FF

Q28244985-366DC163-4479-490C-B9C9-CC34DD98E981

Q28244985-3B1DDF89-1FCB-4FF3-918C-291462A8C77C

Q28244985-3FEAFD2E-56FA-432B-B6AA-607F54B17772

P2888

Q28244985-ED34D0D2-9162-4E77-9053-914C76B39757

P304

Q28244985-058530FD-9793-4B0A-8ACD-9DA2DC18811F

P31

Q28244985-19C2A979-D1B1-438B-9DBD-54796FEFEF45

P3181

Q28244985-C3F1CE16-FC0C-47DC-92E9-B2A4A8F99E0D

P356

Q28244985-6618B338-F0D6-4371-B23B-58C5D9846643

P407

Q28244985-B01B1421-D1BF-4786-9742-737430C0D6BC

P433

Q28244985-52FE0FA6-76E4-4EB4-BA8A-6FF43648E6B8

P478

Q28244985-354C901B-145B-4E5B-8D48-AC312F9DAF97

P577

Q28244985-3863E14D-BC56-49A0-BF05-36453A9511FD

P5875

Q28244985-F2C4F1F3-9B09-4AA3-89D0-7A7C88326697

P6179

Q28244985-6FEB1799-E4AE-40C5-BB9A-AFAA11F2662E

P698

Q28244985-FACDF57E-4159-48E8-85C9-C655EBF8FB7D

P921

Q28244985-509617E4-645D-4C74-B469-5AA3D075797F

Q28244985-84478c77-42ae-cfc9-4f6f-768115a0ff0f

P932

Q28244985-E0DA70E3-6287-4B87-AA28-BD15DC0D5823

P3181

P356

P1433

P1476

Comprehensive molecular characterization of gastric adenocarcinoma

@en

P2860

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Comprehensive molecular characterization of human colon and rectal cancer

PID: the Pathway Interaction Database

Cell migration: integrating signals from front to back

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

Integrated genomic characterization of endometrial carcinoma

The STATs of cancer--new molecular targets come of age

Helicobacter pylori infection and the development of gastric cancer

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

P2888

P304

202-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

142572

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE13480

http://www.w3.org/2001/XMLSchema#string

P407

P433

7517

http://www.w3.org/2001/XMLSchema#string

P478

513

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271212099

http://www.w3.org/2001/XMLSchema#string

P6179

1035707124

http://www.w3.org/2001/XMLSchema#string

P698

25079317

http://www.w3.org/2001/XMLSchema#string

P921

gastric adenocarcinoma

P932

4170219

http://www.w3.org/2001/XMLSchema#string